BridgeMD
New treatment option for Acute Aortic Dissection
Official title A Triple-branched Stent Graft for Aute Debakey Type I Dissection Surgery
ClinicalTrials.gov ID: NCT06492980
What this study is testing
- What it's testing
- Prospective, multicenter, randomized controlled clinical trial plan to evaluate the effectiveness and safety of intraoperative stent system in the treatment of acute type I aortic dissection
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 65
You may be able to join if
- Patients with acute type I aortic dissection who need arch repair;
- Aged ≥20 years and ≤65 years;
- Acute phase, with onset within 14 days before surgery;
- people who can understand the purpose of the trial, voluntarily participate and sign the informed consent form, and are willing to accept follow-up.
You likely can't join if
- The presence of anatomical variations, such as aortic arch malformation, aortic coarctation; common origin of the innominate artery and the left...
- Dissection is secondary to a history of aortic treatment, Marfan syndrome, etc.
- Aortic lesions and branch artery lesions caused by acute type I aortic dissection, including aortic pre-rupture, branch artery rupture, branch artery...
- Severe infectious lesions that are not controlled;
- Patients who need to receive other concomitant treatments, such as severe hypertension, chronic obstructive pulmonary disease, coronary heart...
- Patients with other life-threatening lesions, such as advanced malignant tumors, and whose expected survival time is less than one year;
See the full eligibility criteria
- Patients with acute type I aortic dissection who need arch repair;
- Aged ≥20 years and ≤65 years;
- Acute phase, with onset within 14 days before surgery;
- people who can understand the purpose of the trial, voluntarily participate and sign the informed consent form, and are willing to accept follow-up.
- The presence of anatomical variations, such as aortic arch malformation, aortic coarctation; common origin of the innominate artery and the left common carotid artery, aberrant right subclavian artery, abnormal origin...
- Dissection is secondary to a history of aortic treatment, Marfan syndrome, etc.
- Aortic lesions and branch artery lesions caused by acute type I aortic dissection, including aortic pre-rupture, branch artery rupture, branch artery occlusion, and severe ischemic complications caused by poor organ...
- Severe infectious lesions that are not controlled;
- Patients who need to receive other concomitant treatments, such as severe hypertension, chronic obstructive pulmonary disease, coronary heart disease, chronic kidney disease and other serious underlying lesions that...
- Patients with other life-threatening lesions, such as advanced malignant tumors, and whose expected survival time is less than one year;
- Patients with other lesions in the heart and aorta (patients with other heart diseases that require concurrent heart surgery, such as coronary heart disease, mitral valve disease, tricuspid valve disease, etc.), who are...
- people who have participated in other drug or device clinical trials and have not reached the primary study endpoint; and pregnant women.
The study team makes the final eligibility decision.
Where it's taking place
- Fuzhou, Fujian, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Fuzhou, Fujian, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.